SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AMLMay S.K. Sutherland, Julie A. McEarchern, Django Sussman et al.|Blood|2013Cited by 385
A Potent Anti-CD70 Antibody–Drug Conjugate Combining a Dimeric Pyrrolobenzodiazepine Drug with Site-Specific Conjugation TechnologyScott C. Jeffrey, Peter D. Senter, Nicole M. Okeley et al.|Bioconjugate Chemistry|2013Cited by 246